SIMCERE PHARMAC. GRP LTD Cash Flow Reinvestment Rate
SIMCERE PHARMAC. GRP LTD cash flow reinvestment rate. SIMCERE PHARMAC. GRP LTD (S2P) has a Cash Flow Reinvestment Rate of 0.69x as of December 2025, reinvesting €1.39 Billion (capex €862.20 Million plus investments €-524.90 Million) from operating cash flow of €2.01 Billion. Explore SIMCERE PHARMAC. GRP LTD (S2P) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of SIMCERE PHARMAC. GRP LTD (2022–2025)
Cash flow reinvestment rate of SIMCERE PHARMAC. GRP LTD from 2022 to 2025. Historical reinvestment intensity for SIMCERE PHARMAC. GRP LTD across 4 annual periods. Explore S2P capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
SIMCERE PHARMAC. GRP LTD Cash Flow Reinvestment Rate by Year (2022–2025)
SIMCERE PHARMAC. GRP LTD cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for SIMCERE PHARMAC. GRP LTD. For the full cash flow conversion analysis, see SIMCERE PHARMAC. GRP LTD operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | €1.39 Billion | €2.01 Billion | €862.20 Million | ▼ -24.3% |
| 2024 | 0.91x | €1.27 Billion | €1.39 Billion | €762.57 Million | ▼ -92.6% |
| 2023 | 12.32x | €1.86 Billion | €151.05 Million | €979.86 Million | ▲ +1340.9% |
| 2022 | 0.85x | €1.16 Billion | €1.35 Billion | €678.00 Million | — |